Article
Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathology
2025-06-03
Abstract excerpt
Congenital disorders of glycosylation (CDG) are a group of neurogenetic conditions resulting from disruptions in the cellular glycosylation machinery. The majority of CDG patients have compound heterozygous pathogenic variants in the phosphomannomutase 2 ( PMM2) gene. Individuals with PMM2-CDG exhibit multi-systemic symptoms, prominently featuring neurological deficits with nearly all patients exhibiting cerebell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 032feb38-763e-5317-ad50-4f22c8d15960
- DOI
- 10.1101/2025.06.01.657261
